Recommendations for the management of critically ill patients with COVID-19 in Intensive Care Units.
COVID-19
COVID-19 Testing
COVID-19 drug treatment
Critical care
Críticos
Intensive Care Units
Prueba de COVID-19
SARS-CoV-2
Tratamiento farmacológico de la COVID-19
Unidades de Cuidados Intensivos
Journal
Medicina intensiva
ISSN: 2173-5727
Titre abrégé: Med Intensiva (Engl Ed)
Pays: Spain
ID NLM: 101717568
Informations de publication
Date de publication:
02 2022
02 2022
Historique:
received:
24
08
2021
accepted:
28
08
2021
pubmed:
15
12
2021
medline:
9
2
2022
entrez:
14
12
2021
Statut:
ppublish
Résumé
The COVID-19 pandemic has led to the admission of a high number of patients to the ICU, generally due to severe respiratory failure. Since the appearance of the first cases of SARS-CoV-2 infection, at the end of 2019, in China, a huge number of treatment recommendations for this entity have been published, not always supported by sufficient scientific evidence or with methodological rigor necessary. Thanks to the efforts of different groups of researchers, we currently have the results of clinical trials, and other types of studies, of higher quality. We consider it necessary to create a document that includes recommendations that collect this evidence regarding the diagnosis and treatment of COVID-19, but also aspects that other guidelines have not considered and that we consider essential in the management of critical patients with COVID-19. For this, a drafting committee has been created, made up of members of the SEMICYUC Working Groups more directly related to different specific aspects of the management of these patients.
Identifiants
pubmed: 34903475
pii: S2173-5727(21)00179-X
doi: 10.1016/j.medine.2021.11.019
pmc: PMC8664080
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
81-89Informations de copyright
Copyright © 2021 Elsevier España, S.L.U. and SEMICYUC. All rights reserved.